Navigation Links
SpineMark Appoints Dr. Rudolf Bertagnoli Chairman of International Medical Advisory Board

Leading Non-Fusion Spine Surgeon Supports Company's Goals for Global

Medical Research, Education

SAN DIEGO, Aug. 6 /PRNewswire/ -- SpineMark Corporation, a spine care services organization that partners with hospitals and physicians to develop spine centers, research organizations and medical education training centers, has appointed Dr. Rudolf Bertagnoli, chairman and founder of ProSpine (Bogen, Germany), as chairman of its International Medical Advisory Board. In this role, Bertagnoli will oversee the recruitment of a global panel of physician advisors to manage the development of spine centers of excellence and clinical trials being conducted outside the United States to evaluate new technologies and treatment options for spinal disorders and injuries.

"Dr. Bertagnoli is an active leader in global spinal research studies with more than 20 years of experience pioneering fusion and non-fusion technologies for treatment of spinal disorders," said Marcy T. Rogers, M.Ed., president and CEO of SpineMark. "We believe in bringing together the best spine physicians from around the world to help us build international bridges for education, facility development and clinical research. Dr. Bertagnoli's experience is a great fit to help us achieve our goals of providing advanced spine treatment options to patients on a global level."

Bertagnoli is the founder, CMO and CEO of ProSpine, the first European Centre for Spine Arthroplasty and Associated Non-Fusion Technologies, which has five facilities across Germany. Bertagnoli has been published in key medical journals worldwide, and has trained over 3,000 surgeons from 50 countries in new minimally invasive spine techniques. Additionally, he is the founder and former president of the Spine Arthroplasty Society (SAS), president of Spine Evolution Nucleus Europe (SEN), a member of the North American Spine Society (NASS), a faculty member of IMAST and a past German representative of the International Society for Minimal Intervention in Spinal Surgery (ISMISS).

"SpineMark's concept of integrating clinical research into a global network of centers of excellence resembles the vision I have for my facilities in Germany," said Bertagnoli. "We share a dedication to ensuring that patients can receive quality care. I look forward to contributing to the creation of a global spinal research network through SpineMark's international partnerships."

Bertagnoli graduated in 1984 from the University of Vienna, Austria, and worked at emergency hospitals in Vienna and Linz before moving to the German Center of Spine Surgery in Bad Wildungen, Germany, in 1986. From 1989 to 1994, Bertagnoli held a position as senior physician and head of the spine department at the Orthopedic University Hospital, Georg-August-University Goettingen, Germany. He went on to lead spine units in several German cities before founding ProSpine in 2005.

About SpineMark

SpineMark Corporation is an innovative service organization dedicated to transforming the delivery of spine care. The company partners with hospitals and physicians across the United States and abroad to develop and operate comprehensive, evidence-based spine centers of excellence. By building a global network of spine centers, spine research organizations and state-of-the-art medical conference facilities, SpineMark is improving the overall quality of life of patients afflicted with spine disorders and injuries.

Driven by the specialized experience and expertise of its leadership team and medical advisory board, SpineMark's goal is to create a global network, based on clinically validated best practices for spine care that streamline diagnosis and treatment, simplify referrals and accelerate the recovery process.

SOURCE SpineMark Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
2. SAFC Appoints New Vice President of Quality and Regulatory Affairs
3. Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
4. ARCA biopharma Appoints James Carr as Vice President of Marketing
5. China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors
6. Health Monitoring Systems Appoints Karen S. Dockrell As VP, Sales
7. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
8. Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning
9. Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors
10. AMT Appoints Director Global Marketing and Sales
11. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
Post Your Comments:
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... HART ), a biotechnology company developing bioengineered organ implants ... McGorry will present at the LD Micro "Main ... 2:30 p.m. PT. The presentation will be webcast live ... Management will also be available at the conference for ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
Breaking Biology Technology:
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, ... for U.S. distribution of its DNA library preparation ... and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq ... the preparation of NGS libraries for liquid biopsies--the ... diagnostic and prognostic applications in cancer and other ...
(Date:10/27/2015)... Oct. 27, 2015 In the present market ... concern for various industry verticals such as banking, healthcare, ... the growing demand for secure & simplified access control ... such as hacking of bank accounts, misuse of users, ... such as PC,s, laptops, and smartphones are expected to ...
Breaking Biology News(10 mins):